Table 3.
Variables | HR (95%CI) | p-value |
---|---|---|
a. Main model (any cSS progression) | ||
Age, per year increase | 1.08 (1–1.16) | 0.045 |
Any cSS progression (vs. no progression) | 3.76 (1.37–10.35) | 0.010 |
New lobar CMBs (Yes vs. No) | 0.95 (0.30–3) | 0.926 |
b. Sensitivity analysis model (severity of cSS progression) | ||
Age (for each year increase) | 1.11 (1.02–1.20) | 0.016 |
cSS progression in the same focus/1 new focus | 1.21 (0.22–6.57) | 0.823 |
cSS progression ≥2 new foci | 7.90 (2.47–25.21) | <0.0001 |
New lobar CMBs (Yes vs. No) | 0.76 (0.23–2.46) | 0.644 |
Both models remain consistent/similar effect sizes when additionally adjusted for differences in baseline and follow-up blood-sensitive MRI sequences, sex, cSS presence at baseline and MRI interval (months).